Literature DB >> 8697401

Trends in cancer incidence among children in the U.S.

J G Gurney1, S Davis, R K Severson, J Y Fang, J A Ross, L L Robison.   

Abstract

BACKGROUND: This report provides results of an analysis of temporal trends in childhood cancer incidence in the U.S. stratfied by age, sex, and to a lessor extent, race, within common histologic subtypes.
METHODS: Population-based data from nine registries of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute were analyzed. The analysis was limited to children age < or = 14 years. Cancer cases were restricted to those patients with a malignant neoplasm diagnosed between 1974 and 1991; more than 12,000 children were included. Average annual percentage change in incidence rates and corresponding 95% confidence intervals were estimated from the maximum likelihood method of Poisson regression.
RESULTS: Among children age < or = 14 years there was a 1% average yearly increase (95% CI 0.6, 1.3) in the incidence rates of all malignant neoplasms combined. The average annual percentage change was similar for males and females, and slightly higher for black children compared with white children. Rates increased an average of 2% or more per year for astroglial tumors, rhabdomyosarcomas, germ cell tumors, and osteosarcomas. The average annual percentage change for acute lymphoid leukemia was 1.6% and trends were somewhat stronger for blacks than whites. Cancer trends, in general, were strongest in young children. In particular, increases in astroglial tumors and rhabdomyosarcomas were most apparent among children age < 3 years, and for retinoblastoma and neuroblastoma among children in their first year of life. The average annual percentage change for acute lymphoid leukemia did not vary dramatically with age, however children age < 2 years had stronger trends compared with older children. We found little evidence for increasing trends in Wilms' tumor, primitive neuroectodermal tumors, or hematopoietic neoplasms other than acute lymphoid leukemia.
CONCLUSIONS: These results suggest that cancer occurrence among children within specific histologies increased modestly in the U.S. between 1974 and 1991, and that the increases were most apparent among young children.

Entities:  

Mesh:

Year:  1996        PMID: 8697401     DOI: 10.1002/(SICI)1097-0142(19960801)78:3<532::AID-CNCR22>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  50 in total

1.  Zebrafish models of rhabdomyosarcoma.

Authors:  Eleanor Y Chen; David M Langenau
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

2.  History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care System.

Authors:  Libby M Morimoto; Marilyn L Kwan; Kamala Deosaransingh; Julie R Munneke; Alice Y Kang; Charles Quesenberry; Scott Kogan; Adam J de Smith; Catherine Metayer; Joseph L Wiemels
Journal:  Am J Epidemiol       Date:  2020-10-01       Impact factor: 4.897

3.  Epidemiologic profile of pediatric brain tumors in Morocco.

Authors:  Mehdi Karkouri; Sadia Zafad; Mohammed Khattab; Noureddine Benjaafar; Hanan El Kacemi; Sana Sefiani; Fouad Kettani; Subhojit Dey; Amr S Soliman
Journal:  Childs Nerv Syst       Date:  2010-02-24       Impact factor: 1.475

4.  Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.

Authors:  James G Gurney; Janet E Donohue; Kirsten K Ness; Maura O'Leary; Stephen P Glasser; K Scott Baker
Journal:  Ann Epidemiol       Date:  2007-07-27       Impact factor: 3.797

Review 5.  Gamma Knife treatment of low-grade gliomas in children.

Authors:  Murat Şakir Ekşi; Baran Yılmaz; Akın Akakın; Zafer Orkun Toktaş; Ahmet Cemil Kaur; Mustafa Kemal Demir; Türker Kılıç
Journal:  Childs Nerv Syst       Date:  2015-07-15       Impact factor: 1.475

6.  The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.

Authors:  Khin Thway; Jayson Wang; Dorte Wren; Melissa Dainton; David Gonzalez; John Swansbury; Cyril Fisher
Journal:  Virchows Arch       Date:  2015-04-26       Impact factor: 4.064

7.  Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma.

Authors:  Sara M Federico; Sheri L Spunt; Matthew J Krasin; Catherine A Billup; Jianrong Wu; Barry Shulkin; Gerald Mandell; M Beth McCarville
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Environmental contaminants and children's health: Cause for concern, time for action.

Authors:  G W Chance
Journal:  Paediatr Child Health       Date:  2001-12       Impact factor: 2.253

9.  Anti-insulin growth factor receptor therapy in Ewing sarcoma.

Authors:  Michael S Isakoff; Neyssa Marina
Journal:  F1000 Med Rep       Date:  2009-08-17

10.  The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002.

Authors:  Rachel Eyre; Richard G Feltbower; Peter W James; Karen Blakey; Emmanuel Mubwandarikwa; David Forman; Patricia A McKinney; Mark S Pearce; Richard J Q McNally
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.